Bespoke Extracts files late Form 10-K; revenue up to $1.50M

Bespoke Extracts, Inc. notified the SEC that it will file its Form 10-K for the period ended December 31, 2025 late under Rule 12b-25.

Rhea-AI Filing Summary

Bespoke Extracts, Inc. notified the SEC that it will file its Form 10-K for the period ended December 31, 2025 late under Rule 12b-25. The company states it needs additional time to complete compilation, review, and finalization of financial statements and related disclosures and expects to file no later than fifteen calendar days after the original due date.

The notice discloses an estimated revenue increase to $1,501,000 for the year ended December 31, 2025, up from $1,117,452 for the year ended December 31, 2024. The company is unable to provide an estimate of its net loss for 2025 in this notification.

Insights

Accounting & Reporting Lead

Delay is procedural: additional audit and management review pending; revenue uplift disclosed.

The filing cites ongoing coordination with the independent registered public accounting firm, management review, and the audit committee as the reasons for the late Form 10-K under Rule 12b-25. This is a procedural timing issue rather than a stated audit disagreement.

Revenue for the year ended December 31, 2025 is estimated at $1,501,000 versus $1,117,452 in 2024. The company did not provide a 2025 net loss estimate; subsequent filings will supply complete results.

Key Figures

Filing type: Form 10-K (late filing via Rule 12b-25) Revenue 2025 (estimate): $1,501,000 Revenue 2024 (reported): $1,117,452 +2 more

5 metrics

Filing type Form 10-K (late filing via Rule 12b-25) period ended December 31, 2025

Revenue 2025 (estimate) $1,501,000 year ended December 31, 2025

Revenue 2024 (reported) $1,117,452 year ended December 31, 2024

Expected filing window 15 calendar days after the original due date per Rule 12b-25

Signature date March 31, 2026 notification signed by CEO Michael Feinsod

Key Terms

Rule 12b-25, independent registered public accounting firm, audit committee

3 terms

Rule 12b-25 regulatory

"filed late under Rule 12b-25 because additional time is required"

Rule 12b-25 is an SEC filing provision that lets a company notify regulators and the public that it cannot file a required periodic report (like a quarterly or annual report) on time and explains the reason for the delay. For investors, the notice is a formal heads-up that financial information will arrive late—similar to a company calling to say it will be late turning in homework—so it signals increased uncertainty and may affect trading and risk assessments until the filing is available.

independent registered public accounting firm financial

"ongoing coordination with its independent registered public accounting firm"

An independent registered public accounting firm is an outside accounting company officially registered with the government regulator to examine and report on a public company's financial records and controls. Investors treat its reports like an impartial inspector’s certificate — they add credibility to financial statements, help spot errors or misleading claims, and reduce the risk that shareholders are relying on unchecked or biased numbers.

audit committee governance

"internal reviews by management and the audit committee"

A company's audit committee is a small group of board members who act like independent inspectors for the firm's finances, overseeing how financial reports are prepared, monitoring internal controls, and managing the relationship with external auditors. Investors care because a strong audit committee reduces the risk of accounting errors, fraud, or misleading statements, making financial statements more trustworthy and helping protect shareholder value.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

Why did Bespoke Extracts (BSPK) file a Form 12b-25 for its 2025 Form 10-K?

They requested extra time to finish financial statement compilation and reviews. The company cites coordination with its independent registered public accounting firm and internal and audit committee reviews delaying finalization.

When does Bespoke Extracts (BSPK) expect to file the delayed Form 10-K?

The company expects to file within fifteen calendar days after the original due date. The notification explicitly states it will file no later than fifteen calendar days following the prescribed due date.

What revenue did Bespoke Extracts (BSPK) report for year ended December 31, 2025?

The company estimates revenue of $1,501,000 for the year ended December 31, 2025. It reports prior-year revenue of $1,117,452 for the year ended December 31, 2024.

Did Bespoke Extracts (BSPK) provide a 2025 net income or net loss estimate?

No, the company stated it is unable to provide an estimate of its net loss for the year ended December 31, 2025. The final figures will appear in the forthcoming Form 10-K.

Who signed the Form 12b-25 for Bespoke Extracts (BSPK) and when?

The notification was signed by Michael Feinsod, Chief Executive Officer, and dated March 31, 2026. Contact information for Mr. Feinsod is provided in the notice.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/31/2026 - 12:58 PM Learn about SEC filing dates

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 12b-25

NOTIFICATION OF LATE FILING

(Check One): ☒ Form 10-K ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR

For Period Ended: December 31, 2025

☐ Transition Report on Form 10-K

☐ Transition Report on Form 20-F

☐ Transition Report on Form 11-K

☐ Transition Report on Form 10-Q

☐ Transition Report on Form N-SAR

For the Transition Period Ended: ________________________

Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.

If the notification relates to a portion of the filing checked above, identify the item(s) to which the notification relates:

PART I -- REGISTRANT INFORMATION

Bespoke Extracts, Inc.

Full Name of Registrant

Former Name if Applicable

12001 E. 33rd Avenue, Unit O

Address of Principal Executive Office (Street and Number)

Aurora, CO, 80010

City, State and Zip Code

PART II -- RULES 12b-25(b) AND (c)

If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate.)

	(a)	The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;
☒	(b)	The subject annual report, semi-annual report, transition report on Form 10-K, Form  20-F, Form 11-K, Form N-SAR or Form  N-CSR, or portion thereof, will be filed  on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the  prescribed due date; and
	(c)	The accountant's statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.

PART III -- NARRATIVE

State below in reasonable detail why the Form 10-K, 20-F, 11-K, 10-Q, 10-D, N-SAR, N-CSR or the transition report portion thereof, could not be filed within the prescribed time period. (Attach extra sheets if needed.)

The Company requires additional time to complete the compilation, review, and finalization of its financial statements, related disclosures, and other information necessary for the Form 10-K. This includes ongoing coordination with its independent registered public accounting firm and internal reviews by management and the audit committee. These processes have imposed time constraints that could not be completed without unreasonable effort or expense to the registrant. The registrant expects to file the Form 10-K no later than fifteen calendar days after the original due date.

PART IV -- OTHER INFORMATION

(1) Name and telephone number of person to contact in regard to this notification

Michael Feinsod		720		949-1143
(Name)		(Area Code)		(Telephone Number)

(2) Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If the answer is no, identify report(s).      ☒ Yes     ☐ No

(3) Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?

☒ Yes        ☐  No

If so: attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.

The Company estimates that revenue for the year ended December 31, 2025, increased to approximately $1,501,000 from $1,117,452 for the year ended December 31, 2024. The Company is unable to provide an estimate of its net loss for the year ended December 31, 2025.

2

Bespoke Extracts, Inc.

(Name of Registrant as Specified in Charter)

Has caused this notification to be signed on its behalf by the undersigned thereunto duly authorized.

Date: March 31, 2026	By:	/s/ Michael Feinsod
	Name: Title:	Michael Feinsod Chief Executive Officer

3